Listed

Cellectar Biosciences, Inc.: Form 10-K/A for the period ended Dec 31, 2022

Filed with the SEC on Mar 16, 2023 and accepted by EDGAR at Mar 16, 2023, 16:36 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Source: SEC EDGAR, the filing index for accession 0001104659-23-033350. Last ingested by Listed: Nov 10, 2026, 16:55 ET. Listed shows no prices and gives no investment advice.